ESMO - Eur. Oncology
@myESMO
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
#AntiDrugConjugates in #LungCancer. In an Opinion piece in the #ESMODailyReporter, @TonyMok9 reviews data from recent #ClinicalTrials using HER2-, HER3- on TROP2-targeted #ADCs. 🔗 ow.ly/tw6T50Wsi4H #ESMOTATAsia25
#ESMOTATAsia25: In an Opinion piece in the #ESMODailyReporter, @lillian_siu discusses the growth of early #oncology #ClinicalTrials in #AsiaPacific but highlights the need for improved trial access in low- and middle-income countries. 🔗 ow.ly/irKY50Wsc8e
#ESMO4Carers: Healthcare professionals often face workplace challenges and pressures. @DrHelenGarr highlights common challenges and offers valuable advice on developing #resilience. @BanerjeeSusana @DrJonLim
📣You only have a few days left to submit your research to EMUC25! Take this opportunity to share your work at a globally influential multidisciplinary congress and join leading experts in defining best practices in genito-urinary cancers treatment. 🔗 ow.ly/Er3o50WnBuT
Stay ahead with the #ESMOVirtualJournalClub – July 2025! We’re diving into new studies on #NSCLC and #GEJ cancers. Register now: 🔗 ow.ly/7Gty50WsGcz
#ESMO4Carers: ESMO #Resilience Task Force Workshop participants highlight initiatives to foster #wellbeing of the #OncologyWorkforce. @BanerjeeSusana @DrJonLim @DrMickButton @VilmaPBarcia
📖 The ESMO Targeted Anticancer Therapies Asia Congress 2025 resources are now available on OncologyPro. 🔗 ow.ly/Viz850WsBP8 📚Explore cutting-edge discoveries and expert-led discussions from #ESMOTATAsia25 - where the science of early-phase oncology meets innovation.…
Early start to Day 2 #ESMOTATAsia25 with some stats! Dr @anmwongNZ on how to report subgroup analyses in RCTs; IPASS as a good eg w good biological rationale; limitations of a priori & exploratory; photos of Prof Mok an added bonus 🤣 @myESMO
Always so inspiring @AACRPres Prof Lilian Siu’s Keynote insights @myESMO #ESMOTATAsia25 🌏Play to our strengths & 👀 opportunities to collab/complementary trials 🌏Strategies to improve equity/access to trials 🌏visions for P1 trials to be patient focus, not just 💊focused
Honored to receive a merit travel grant and deliver an oral presentation at this exceptionally well-organized meeting. The food has been excellent too! 🙏 ✨@myESMO #ESMOTATAsia25
#ESMOTATAsia25: Exploratory #omics and #MachineLearning revealed an 11-gene signature associated with response after #chemoradiotherapy for #CervicalCancer. MMP2 was identified as a key target. Read more in the #ESMODailyReporter. 🔗 ow.ly/cGlr50WscfM
Great first day @myESMO #ESMOTATAsia25 🤩great cellular therapies panel: 🗣️ on-target off-tumour tox 🗣️when to best use it/best combo 🤩@apoddc survey highlighting barriers for trials & need for 🌏collabs @pankajpanda86 @herbloong @danieltanmd @DrBenTran
#ESMOTATAsia25: Presentations highlight the value of integrating #PatientReportedOutcomes (#PRO) into #EarlyPhaseTrials with guidance on standardisation. Read more in the #ESMODailyReporter 🔗 ow.ly/e6MG50WrFqq
What a way to kick off the inaugural #ESMOTATAsia25 @myESMO
🙌 Welcome to #ESMOTATAsia25! The Congress kicks off today — get ready for cutting-edge insights in targeted therapies and early drug development. 👉 Join us to accelerate novel cancer therapeutics across the APAC region: #Oncology #CancerResearch 🔗 ow.ly/6pW250Woc2Z
👉 Don't miss the opportunity to learn the fundamentals of epidemiology aetiology, pathogenesis, molecular events, and ethnic patterns as contributing factors to heterogeneity in Gastric Cancer. ⏰ Application deadline: 27 August 2025 🔗 ow.ly/4ZMF50Wg0ZP
📣 #ESMOImmuno25: Share your new data in a platform where early discoveries meet clinical implementation—accelerating progress from bench to bedside. ⏰ Submission deadline: 30 September 2025 🔗 ow.ly/mhcy50Wnw14
📣 ESMO Living Guidelines on Metastatic Colorectal Cancer v1.3: Updated recommendations and algorithms for the treatment of patient with BRAF-mut. 🔗 ow.ly/Vvst50WpHFh #ESMOGuidelines @ChiaraCrem1 @erikamartin3lli @AndresC27622123
In the Diary of an Oncology Leader video series by #ESMOW4O @marinagarassino shares the key lessons that continue to influence her leadership style 👉 Stay tuned for the next episode featuring @DrAngelaLamarca 🔗 ow.ly/iC0350Wp6Oe #ESMODailyReporter #OncologyLeadership
